<strong>Efficacy and adverse reactions of metronomic chemotherapy in recurrent and metastatic breast cancer: a meta-analysis</strong>

doi:10.3781/j.issn.1000-7431.2022.2108-0547

PDF(2847 KB)

Tumor ›› 2022, Vol. 42 ›› Issue (05) : 345-356. DOI: 10.3781/j.issn.1000-7431.2022.2108-0547

Efficacy and adverse reactions of metronomic chemotherapy in recurrent and metastatic breast cancer: a meta-analysis

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 42(05): 345-356 https://doi.org/10.3781/j.issn.1000-7431.2022.2108-0547

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(2847 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Accepted	Published
2021-08-05	2022-03-10	2022-05-25
Issue Date
2022-05-25

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

QR code of this article

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS